20
Participants
Start Date
March 14, 2019
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
No intervention, this is a natural history progression study
The objective is to better understand the disease process of CNGB1-RP so that we can develop clinical tests to measure the outcomes of treatment.
RECRUITING
Dr. Stephen H. Tsang, New York
RECRUITING
Wills Eye Hospital, Philadelphia
RECRUITING
Klinikum der Universität München University Eye Hospital, Ludwig-Maximilians-University (LMU) Munich, München
RECRUITING
Institut de la Vision/Centre de maladies rares du Centre Hospitalier National Ophtalmologique des Quinze-Vingts, Paris
RECRUITING
Eberhard Karls University Tubingen, Tübingen
NOT_YET_RECRUITING
Moorfields Eye Hospital NHS Foundation Trust, London
Michigan State University
OTHER
Moorfields Eye Hospital NHS Foundation Trust
OTHER
Universität Tübingen
OTHER
Wills Eye
OTHER
La Fondation Voir et Entendre
UNKNOWN
Ludwig-Maximilians - University of Munich
OTHER
Columbia University
OTHER